openPR Logo
Press release

Hemoglobinopathies Market 2019 With Abbott, Bio-Rad Laboratories, Danaher, Nexcelom Bioscience, NIHON KOHDEN, PerkinElmer, Siemens, Sysmex Corporation, Novartis AG, Medunik

07-29-2019 04:09 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Hemoglobinopathies Market

Hemoglobinopathies Market

Being an excellent market research report, this hemoglobinopathies report serves as a backbone for your business when it is about thriving in the competition. The report is all-embracing global market research report and it identifies, analyses, and estimates the emerging trends along with major drivers, challenges and opportunities in the hemoglobinopathies industry along with the analysis of retailers, geographical regions, types, and applications. The report studies wide-ranging industry analysis with exact estimates and forecasts that provides complete research solutions with maximum industry clarity. Thus, the hemoglobinopathies report is the best solution for businesses if they want to stay ahead of the competition in today's rapidly moving business landscape.

The hemoglobinopathies report provides estimations about the growth rate and the market value based on market dynamics and growth inducing factors. Businesses can get current as well as upcoming technical and financial details of the industry to 2026 with this market research report. The report is mainly distributed to the users in the form of PDF or spreadsheet or PPT (if asked by client). The report also mentions CAGR value fluctuations during the forecast period of 2018-2025 for the market. The hemoglobinopathies report has been formulated with the best-practice models, comprehensive market analysis and research methodologies so that clients attain perfect market segmentation and insights.

Global hemoglobinopathies market is expected to rise to an estimated value of USD 12.75 billion by 2026, registering a CAGR of 10.45% in the forecast period of 2019-2026. High prevalence of hemoglobinopathies is the major factor for the growth of this market.


Get Free Sample Analysis of This Market Information: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemoglobinopathies-market


Hemoglobinopathies is a group of disorder which is associated with the blood and usually affects the red blood cell. Sickle cell anemia, thalassemias, hemoglobin C disease and hemoglobin S-C disease are some of the common hemoglobinopathies disease. They are usually detected by test like routine red blood cell count, high performance liquid chromatography, hemoglobin isoelectric focusing etc. They are usually inherited from single-gene disorders.

Key Market Competitors: Global Hemoglobinopathies Market

Few of the major competitors currently working in the global hemoglobinopathies market are Abbott, Bio-Rad Laboratories, Inc., Danaher, Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Nexcelom Bioscience LLC, NIHON KOHDEN CORPORATION, PerkinElmer Inc., Siemens, Sysmex Corporation, Novartis AG, Medunik USA Inc, Emmaus Medical, Bristol-Myers Squibb Company, ApoPharma Inc, Alnylam Pharmaceuticals, Inc., Gamida Cell, Biogen, Acceleron Pharma, Inc, Sangamo Therapeutics, CELGENE CORPORATION.

Market Drivers

· Rising awareness about hemoglobinopathies among consumer is driving the market growth

· Improvement in healthcare infrastructure is driving the market

· Increasing blood cancer cases among population is driving the growth of this market.

· Favorable government programs related to hemoglobinopathies will propel the market


Get TOC For Full Analysis Of Report: https://databridgemarketresearch.com/toc/?dbmr=global-hemoglobinopathies-market


Segmentation: Global Hemoglobinopathies Market

By Indication

· Sickle Cell Disease

· Beta Thalassemia

· Alpha Thalassemia

By End- User

· Hospitals

· Diagnostics Laboratories

· Clinics

By Test Type

· Routine Red Blood Cell (RBC) Count

· Genetic Testing

· Hemoglobin by High Performance Liquid Chromatography

· Hemoglobin Isoelectric Focusing (Hb IEF)

· Hemoglobin electrophoresis (Hb ELP)

· Hemoglobin Solubility Test

By Pipeline Therapeutics

· NiCord, ZFP Transcription Factors

· ALN-TMP

· Drug Targeting PRMT5

· Drug Targeting Protein Arginine Methyltransferase 5

By Geography

· North America

o U.S.

o Canada

o Mexico

· South America

o Brazil

o Argentina

o Rest of South America

· Europe

o Germany

o France

o United Kingdom

o Italy

o Spain

o Russia

o Turkey

o Belgium

o Netherlands

o Switzerland

o Rest of Europe

· Asia-Pacific

o Japan

o China

o South Korea

o India

o Australia

o Singapore

o Thailand

o Malaysia

o Indonesia

o Philippines

o Rest of Asia Pacific

· Middle East & Africa

o South Africa

o Egypt

o Saudi Arabia

o United Arab Emirates

o Israel

o Rest of Middle East & Africa

Key Developments in the Market:

· In November 2016, Sangamo BioSciences, Inc announced the transfer of zinc finger nuclease (ZFN)-mediated genome editing program for hemoglobinopathies to Bioverativ. This helps the Bioverativ to meet the rising medical need of patient with blood disorders. It will also help the company to advance these programs. This program is very useful to treat two blood disorders, beta- thalassemia and sickle cell disease.

· In January 2014, Biogen Idec and Sangamo BioSciences together announced the launch of their new platform for the treatment of sickle cell disease (SCD) and beta thalassemia. This collaboration will help the Biogen to expand their business and to provide treatment to the patients with serious inherited hematologic conditions.

Want Full Report? Make Inquiries For Your Custom Requirements: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemoglobinopathies-market

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
https://databridgemarketresearch.com

About Us

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemoglobinopathies Market 2019 With Abbott, Bio-Rad Laboratories, Danaher, Nexcelom Bioscience, NIHON KOHDEN, PerkinElmer, Siemens, Sysmex Corporation, Novartis AG, Medunik here

News-ID: 1813759 • Views: 2534

More Releases from Data Bridge Market Research

Water Treatment Chemicals Market 2020 : Witnessing Enormous Growth and Booming W …
The Global Water Treatment Chemicals Market is expected to reach USD 61.86 billion by 2026, from USD 43.6 billion in 2017 growing at a CAGR of 7.9 % during the forecast period of 2020 to 2026 Moreover increasing industrial activities and growth in world population are augmenting the market for the water treatment chemicals across the globe. Increasing water treatment chemicals prices and presence of alternate treatment technologies are predicted to
Robotic Process Automation (RPA) Market Competitive Outlook: Automation Anywhere …
A new business intelligence report released by Data Bridge Market research with titled "Global Robotic process automation Market" (covering USA, Europe, China, Japan, India, South East Asia and etc) that targets and provides comprehensive market analysis with future prospects to 2026. This rise in the market can be attributed due to rising popularity and attractiveness of enterprise resource planning which is driving the needs of the business to
Digital Assurance Market Competitive Outlook: Atos, Accenture, Capgemini, Cignit …
Data Bridge Market researchhas recently released expansive research on Global Digital Assurance Market with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis. The report endows with wide-ranging statistical analysis of the market's continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. This market report provides best solutions for strategy development and implementation depending on client's needs to extract tangible
Rear E Axle Market Future Outlook | ZF Friedrichshafen AG, Schaeffler AG,Contine …
Front rear E axle market will register the growth rate of 23.50% for the forecast period of 2020 to 2027. Rising usage of E-axle in ICE vehicles is expected to create new opportunity for the market. Growing sales of electric and hybrid vehicles is expected to enhance the market growth. Some of the other factors such as increasing cost of the fuels, strict emissions rules to decrease the vehicle weight

All 5 Releases


More Releases for Hemoglobin

Global Hemoglobin Analyzers Market Research Report
This report studies the global Hemoglobin Analyzers market status and forecast, categorizes the global Hemoglobin Analyzers market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report EKF Diagnostics HemoCue ManthaMed ApexBio Boditech Med Inc. CERAGEM Medisys DiaSys Diagnostic Systems GmbH Fenwal Fresenius Kabi
New Trends and Key Developments in Glycated Hemoglobin Testing Market
Global glycated hemoglobin testing market is projected to reach a valThe global glycated hemoglobin testing market is segmented on the basis of type, technique, end user, and region.ue of over US$ 650 Mn in 2026 at a CAGR of 8.6% over the forecast period. Glycated hemoglobin testing is used to measure concentration of blood glucose in individuals. HbA1c, is a chemical form of glycated hemoglobin, a protein within red blood
Global Hemoglobin Analyzer Market Insights, Forecast to 2025
This report studies the global market size of Hemoglobin Analyzer in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Hemoglobin Analyzer in these regions. This research report categorizes the global Hemoglobin Analyzer market by top players/brands, region, type and end user. This report also studies the global Hemoglobin Analyzer market status, competition landscape, market share, growth rate, future
Glycated Hemoglobin Testing Market: Prevalence of Diabetes to Bolster Demand for …
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.
Glycated Hemoglobin Testing Market: Prevalence of Diabetes to Bolster Demand for …
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.
Glycated Hemoglobin Testing Market 2017 Share, Trend, Segmentation and Forecast
Increasing incidences of diabetes have propelled the need for improved diagnostics in the global healthcare devices. Companies manufacturing critical diagnostic devices are focusing on facilitating products for effective tests. The use of glycated hemoglobin in diagnosis of diabetes mellitus continues to gain traction, creating a steady demand for glycated hemoglobin testing. Transparency Market Research’s recent report on the global glycated hemoglobin testing market delivers a forecast outlook on growing demand for these